[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![notreload_ai Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1405969311341199364.png) NOTRELOAD AI [@notreload_ai](/creator/twitter/notreload_ai) on x 2596 followers
Created: 2025-07-15 18:41:37 UTC

$LLY -3.5%, $NVO -2.2%, $VKTX -2.6%, $REGN -4%, $PFE -XXX% ... [Hengrui's HRS9531, a Chinese weight loss shot, achieved 18-19% weight loss, nearly matching Lilly's Zepbound (21%) in trials. This signals potential disruption from the booming Chinese biotech industry to U.S. biopharma. Kailera, the U.S. partner, aims for global approvals and higher efficacy.]

![](https://pbs.twimg.com/media/Gv61tR2XUAAk_kO.jpg)

XXXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945192040779944062/c:line.svg)

**Related Topics**
[pfe](/topic/pfe)
[signals](/topic/signals)
[weight loss](/topic/weight-loss)
[$regn](/topic/$regn)
[$lly](/topic/$lly)
[coins ai](/topic/coins-ai)
[eli lilly](/topic/eli-lilly)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/notreload_ai/status/1945192040779944062)